BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4008158)

  • 1. Etretinate improves localized porokeratosis of Mibelli.
    Campbell JP; Voorhees JJ
    Int J Dermatol; 1985 May; 24(4):261-3. PubMed ID: 4008158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkeratotic porokeratosis (Mibelli) with psoriasis--response to an aromatic retinoid.
    Beer WE; Smith NP
    Clin Exp Dermatol; 1984 Sep; 9(5):509-13. PubMed ID: 6488582
    [No Abstract]   [Full Text] [Related]  

  • 3. Etretinate in the treatment of disseminated porokeratosis of Mibelli.
    Hacham-Zadeh S; Holubar K
    Int J Dermatol; 1985 May; 24(4):258-60. PubMed ID: 4008157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated porokeratosis Mibelli treated with RO 10-9359. A study of two cases with ultrastructural remarks.
    Bundino S; Zina AM
    Dermatologica; 1980; 160(5):328-36. PubMed ID: 7364142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with an oral aromatic retinoid in linear porokeratosis.
    Pehamberger H; Konrad K
    Dermatologica; 1980; 160(4):270-4. PubMed ID: 7358191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized eruptive porokeratosis of Mibelli with associated psoriasis.
    Eng AM; Kolton B
    J Cutan Pathol; 1975; 2(4):203-13. PubMed ID: 1202108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of superficial disseminated actinic porokeratosis treated with an aromatic retinoid].
    Ludera-Zimoch G; Rubisz-Brzezińska J
    Przegl Dermatol; 1989; 76(1):54-7. PubMed ID: 2813819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases.
    Christiansen JV; Holm P; Reymann F; Thestrup-Pedersen K
    Dermatologica; 1984; 168(3):122-6. PubMed ID: 6714503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids in psoriasis and disorders of keratinization.
    Fritsch PO
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S8-14. PubMed ID: 1460124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of PUVA-induced keratoses to etretinate.
    Hudson-Peacock MJ; Angus B; Farr PM
    J Am Acad Dermatol; 1996 Jul; 35(1):120-3. PubMed ID: 8682951
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP; Finlay AY
    Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinoids and the prevention of cutaneous epitheliomas: 1977-1987].
    Schnitzler L
    Ann Dermatol Venereol; 1987; 114(12):1537-43. PubMed ID: 3445984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M; Paravicini U
    J Am Acad Dermatol; 1984 Apr; 10(4):632-8. PubMed ID: 6715613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digitate keratoses--a complication of etretinate used in the treatment of disseminated superficial actinic porokeratosis.
    Carmichael AJ; Tan CY
    Clin Exp Dermatol; 1990 Sep; 15(5):370-1. PubMed ID: 2146049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment with aromatic retinoid (Ro 10-9359) for some diseases with keratinizing disorders.
    Timpatanapong P; Puavilai S; Polnikorn N; Tasanapradit P; Charuwichitratana S
    J Med Assoc Thai; 1985 Feb; 68(2):49-59. PubMed ID: 4009086
    [No Abstract]   [Full Text] [Related]  

  • 17. Etretinate kinetics during chronic dosing in severe psoriasis.
    Massarella J; Vane F; Buggé C; Rodriguez L; Cunningham WJ; Franz T; Colburn W
    Clin Pharmacol Ther; 1985 Apr; 37(4):439-46. PubMed ID: 3979005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of disseminated superficial actinic porokeratosis with a new aromatic retinoid (Ro 10-9359).
    Kariniemi AL; Stubb S; Lassus A
    Br J Dermatol; 1980 Feb; 102(2):213-4. PubMed ID: 7387874
    [No Abstract]   [Full Text] [Related]  

  • 19. Etretinate therapy and immune reactivity.
    Jensen JR; El'Ramley M; Herlin T; Kragballe K; Thestrup-Pedersen K
    Arch Dermatol Res; 1983; 275(4):259-60. PubMed ID: 6625655
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progressive symmetric erythrokeratodermia. Report of a case with delayed onset treated by etretinate].
    Borbujo Martinez J; Casado Jimenez M; Jimenez Acosta F; Almagro Sanchez M; Martinez Gomez W; Soto Melo J
    Med Cutan Ibero Lat Am; 1988; 16(3):236-8. PubMed ID: 2974108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.